RxDoctor Payments Data

April Turner

Family · Russell Springs, KYNPI 1821760018

Payments from drug & device makers

$1,670in general payments, 2019–2025

Across 93 payments — averaging $17.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$415
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$186
  • Novo Nordisk$174
  • Lilly USA, LLC$116
  • Bayer$107
  • AbbVie$91
  • plus $580 from 15 others

What the payments were for

  • Food & beverage$1,670100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,670 in reported general payments places this provider in the 75th percentile of 4,374 family providers in Kentucky.

See all family providers in Kentucky

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide62$58,288
JardianceEmpagliflozin28$22,070
EliquisApixaban28$20,454
Trelegy ElliptaFluticasone/Umeclidin/Vilanter31$18,633
TrulicityDulaglutide11$11,471
LinzessLinaclotide12$7,441
MyrbetriqMirabegron15$6,533
Combivent RespimatIpratropium/Albuterol Sulfate12$5,894
Dexlansoprazole DrDexlansoprazole11$2,968
Albuterol Sulfate HfaAlbuterol Sulfate77$2,579
Ventolin HfaAlbuterol Sulfate44$2,493
Lantus SolostarInsulin Glargine,hum.Rec.Anlog18$2,260
Levothyroxine Sodium120$839
Gabapentin85$837
Omeprazole129$628

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$174$58,28862 claims
Boehringer IngelheimJardiance, Combivent Respimat$47$27,96440 claims
PfizerEliquis$73$20,45428 claims
GSKTrelegy Ellipta$57$18,63331 claims
Lilly USA, LLCTrulicity$116$11,47111 claims
AbbVieLinzess$91$7,44112 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 4,374 family providers in Kentucky.

Other family in Russell Springs

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →